Virginia Silvari: Privilege to Take Part In the 3rd Antithrombotic Stewardship Summit by ISTH and Anticoagulation Forum
Virginia Silvari, Chief II Pharmacist- Education and Research at Health Service Executive, shared on LinkedIn:
”What a privilege to take part in the 3rd Antithrombotic Stewardship Summit, jointly organised by the Anticoagulation Forum and International Society on Thrombosis and Haemostasis (ISTH)!
Huge thanks to Vivien Tham for being such a brilliant co-presenter, and to Tara Lech, PharmD, CACP and Nibal Chamoun, PharmD,BCPS,CACP for steering the discussion so thoughtfully of our session:
Early adopters- Experiences of International Centers of Excellence.
We shared how stewardship models can move beyond individual hospitals to shape national practice, drawing on lessons from Ireland’s and Singapore’s antithrombotic stewardship landscape.
It was energising to be in Paris in a room with clinicians, pharmacists, nurses and researchers from around the world, all pushing the same goal forward: safer, smarter antithrombotic care for patients.
Thanks to the Anticoagulation Forum and International Society on Thrombosis and Haemostasis (ISTH) for creating this great platform for global exchange.”
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 23:19Zeyad Kholeif: New Evidence Challenges Routine Triple Antithrombotic Therapy After Anterior STEMI
-
Jul 12, 2026, 22:53Mildred Lundgren: No Patient with HHT Should Face a Postcode Lottery for Life-Saving Care
-
Jul 12, 2026, 21:40Dino Mehic: New Real-World Evidence on DOAC Safety After Childbirth
-
Jul 12, 2026, 20:44Mary Cushman: Starting ISTH 2026 With Women’s Thrombosis and Hemostasis Health
-
Jul 12, 2026, 20:43Elif Güler Kazanci: Honored to Attend ISTH 2026
-
Jul 12, 2026, 20:41Anna Waterhouse: Exciting First Day at the ISTH 2026
-
Jul 12, 2026, 20:39Ghadir Alkarithi: Exploring the Latest Advances at ISTH 2026
-
Jul 12, 2026, 20:21Rainer Kaiser: How T Cells Boost Myeloid Effector Functions in Endocarditis
-
Jul 12, 2026, 17:04Marc Carrier: EPCAT III Trial at ISTH 2026 Supports Aspirin Alone for VTE Prevention After Arthroplasty